SecSonar.com

Amarin Corporation plc (AMRN)

Amarin Corporation plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Amarin Corporation plc (AMRN) is a Biotechnology company based in IE with a market capitalization of $302.3M. Revenue declined 6.5% year-over-year and the company generated $6.7M in free cash flow. This page tracks AMRN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IE · 275 employees · IPO Apr 1, 1993

Valuation

Valuation & price

$14.25 · as of May 26, 2026 · -29.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.66

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.07$16.84$13.60Jul 25Dec 25Jul 26Jul 7, 25$16.65Jul 9, 25$17.33Jul 11, 25$16.93Jul 15, 25$15.78Jul 17, 25$15.79Jul 21, 25$15.55Jul 23, 25$15.59Jul 25, 25$15.39Jul 29, 25$14.65Jul 31, 25$14.52Aug 4, 25$15.38Aug 6, 25$15.05Aug 11, 25$14.94Aug 13, 25$15.00Aug 15, 25$15.65Aug 19, 25$15.82Aug 21, 25$15.82Aug 25, 25$15.39Aug 27, 25$15.47Aug 29, 25$15.04Sep 3, 25$15.04Sep 5, 25$15.33Sep 9, 25$15.22Sep 11, 25$14.97Sep 16, 25$14.93Sep 18, 25$14.92Sep 22, 25$15.38Sep 24, 25$15.44Sep 26, 25$16.00Sep 30, 25$16.38Oct 2, 25$16.74Oct 6, 25$19.33Oct 8, 25$19.28Oct 10, 25$18.23Oct 14, 25$19.32Oct 16, 25$20.07Oct 21, 25$19.94Oct 23, 25$19.46Oct 27, 25$19.24Oct 29, 25$16.81Oct 31, 25$16.29Nov 4, 25$15.20Nov 6, 25$15.67Nov 10, 25$15.85Nov 12, 25$16.21Nov 14, 25$16.34Nov 18, 25$16.71Nov 20, 25$16.43Nov 25, 25$15.72Nov 28, 25$15.97Dec 2, 25$15.53Dec 4, 25$16.46Dec 8, 25$14.92Dec 10, 25$14.25Dec 12, 25$14.36Dec 16, 25$13.97Dec 18, 25$13.83Dec 22, 25$13.60Dec 24, 25$13.70Dec 29, 25$14.04Jan 2, 26$13.72Jan 6, 26$13.69Jan 8, 26$16.40Jan 12, 26$15.56Jan 14, 26$15.01Jan 16, 26$14.78Jan 21, 26$15.29Jan 23, 26$16.26Jan 27, 26$15.69Jan 29, 26$15.42Feb 2, 26$15.00Feb 4, 26$14.60Feb 9, 26$14.75Feb 11, 26$15.11Feb 13, 26$14.74Feb 18, 26$15.76Feb 20, 26$15.59Feb 24, 26$15.52Feb 26, 26$14.12Mar 2, 26$13.93Mar 4, 26$14.54Mar 6, 26$14.06Mar 10, 26$15.97Mar 12, 26$16.37Mar 17, 26$15.52Mar 19, 26$15.00Mar 23, 26$14.60Mar 25, 26$14.68Mar 27, 26$14.45Mar 31, 26$14.46Apr 2, 26$14.74Apr 7, 26$14.69Apr 9, 26$14.78Apr 13, 26$14.51Apr 15, 26$15.20Apr 17, 26$14.98Apr 22, 26$14.50Apr 24, 26$14.31Apr 28, 26$13.96Apr 30, 26$13.93May 4, 26$14.24May 6, 26$14.90May 8, 26$15.05May 12, 26$14.95May 14, 26$14.78May 18, 26$14.06May 20, 26$14.27May 22, 26$14.43May 28, 26$14.41Jun 1, 26$14.36Jun 3, 26$14.53Jun 5, 26$13.93Jun 9, 26$14.89Jun 11, 26$14.90Jun 15, 26$15.35Jun 17, 26$15.77Jun 22, 26$15.81Jun 24, 26$16.41Jun 26, 26$15.91Jul 2, 26$16.37
$13.5052-week range$20.25
Loading valuation history…

Fundamentals

Key fundamentals

$302.3M

Market cap

-6.5%

Revenue growth (YoY)

56.6%

Gross margin

$6.7M

Free cash flow (USD)

-$290.6M

Net debt

Net cash position

1.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$130.1MFY 2017$181.1MFY 2018$229.2MFY 2019$429.8MFY 2020$614.1MFY 2021$583.2MFY 2022$369.2MFY 2023$306.9MFY 2024$228.6MFY 2025$213.6M
$130.1M$213.6M

Free cash flow by year

2016 → 2025

FY 2016$-71.8MFY 2017$-32.8MFY 2018$-94.8MFY 2019$-11.8MFY 2020$-22.0MFY 2021$-66.5MFY 2022$-180.0MFY 2023$6.9MFY 2024$-31.0MFY 2025$6.7M
-$71.8M$6.7M

Gross margin by year

2021 → 2025

FY 202179.2%FY 202265.7%FY 202353.9%FY 202435.6%FY 202556.6%
79.2%56.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 15, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing
  • Quarterly report10-Q FiledApr 29, 2026Filing

Questions

Frequently asked questions

What is Amarin Corporation plc's market cap?

Amarin Corporation plc (AMRN) has a market capitalization of $302.3M.

What is AMRN's P/E ratio?

A meaningful P/E ratio is not available for AMRN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AMRN's price-to-book (P/B) ratio?

AMRN trades at 0.66 times book value per share.

Are insiders buying AMRN stock?

SEC Form 4 filings show no open-market insider buys at Amarin Corporation plc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

VSTM

Verastem, Inc.

$303.9M

ARMP

Armata Pharmaceuticals, Inc.

$300.3M

ENTA

Enanta Pharmaceuticals, Inc.

$305.7M

XOMAP

XOMA Corporation

$307M

NAGE

Niagen Bioscience Inc

$311.8M

ZNTL

Zentalis Pharmaceuticals, Inc.

$290.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.